跳至主要内容
临床试验/NCT01778725
NCT01778725Unknown不适用

S100B as a Marker for Fetal Brain Injury in Premature Rupture of Membranes

Sheba Medical Center1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
入组人数
90
试验地点
1
主要终点
Developmental assessment

研究概览

简要总结

Premature breaking of the amniotic fluids during pregnancy caries high risk for infection of the amniotic fluid. One of the results of chorioamnionitis is brain injury of the fetus. Fetus' brain is highly vulnerable and could be harmed even by mild inflammation before fulminant infection is developed. The aim of this study is to identify, as early as, possible signs of brain injury. S100B protein will be used as a marker for brain insult. S100b level were associated with the occurrence and size of stroke and brain trauma in adults and children. Moreover, S100B crosses the membrane and its level in women with preterm labor was associated with brain injury of preterm infant.

The study question is whether the levels of S100B in women with early amniotic fluids breakdown are associated with future brain injury of the infant, as assessed by head ultrasound and neurological examination.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Rupture of the amniotic sac before 32 weeks
  • Gestational age less than 32 weeks
  • Singleton

排除标准

  • Intrauterine growth restriction
  • Positive TORCH
  • Fetus' brain malformation
  • Fetus' brain hemorrhage
  • Maternal medication with teratogenic effect

结局指标

主要结局

Developmental assessment

时间窗: 3 month

Developmental assessment at term and 3 month 1. Neurological examination 2. Test of infant motor performance

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验